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The purpose of this review is to outline our 
current knowledge of the genetic regulation of the 
IgE antibody response. This response is governed 
in part by specific immune response (lr) genes, 
which determine the ability to respond well or 
poorly to specific antigens, and which are linked to 
the genetic region determining the structure of the 
major transplantation antigens of the species. This 
association between genetic controls of specific 
immune responses and the major transplantation 
antigen complex has led to the discovery of a 
remarkable number of associations between partic-
ular transplantation antigen types and susceptibil-
ity to a wide variety of diseases . The second part of 
the discussion will deal briefly with the association 
between the human major transplantation antigen 
complex (the human leukocyte antigen, or HLA 
complex), and several dermatologic diseases. 
STRUCTURE AND FUNCTION OF THE MAJOR 
TRANSPLANTATION COMPLEX 
Figure 1 is a schematic diagram of the genetic 
structure of the chromosomal region determining 
the structure of the major transplantation antigens 
of the mouse (the H-2 complex) and of man (the 
HLA complex). In the mouse, the H-2K and H-2D 
loci determine the structure of a highly polymor-
phic set of cell surface glycoproteins of 45,000 mo-
lecular weight (MW) which are found on the surface 
of all cells of the body, including red cells and 
platelets. These were the original transplantation 
antigens detected by both serologic and skin graft-
ing techniques, and they have a counterpart in 
man in the HLA-A, B, and C loci which determine 
the structure of a similar series of 45,000-MW cell 
surface glycoproteins with a ubiquitous tissue 
distribution. In the Figure, the most recent letter 
designation of these loci is given on the top of the 
chromosomal diagram, and synonyms for these loci 
which are in the earlier literature are placed below 
each of the gene symbols. Thus, the HLA-A locus 
was formerly known as the LA locus, and then was 
designated as the SD-l, for serologically detectable 
first locus. The HLA-B locus was earlier known as 
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the 4 locus, or SD-2, for serologically detectable 
second locus. The HLA-C locus is the current name 
for a recently described locus, AJ, determining the 
structure of cell surface glycoproteins similar to 
HLA-A and B gene products. These letter designa-
tions were agreed upon at the 1975 Histocompati-
bility Testing Workshop (1). 
The diagram shows that genes controlling spe-
cific immune responses, the Ir genes, map in the 
center of the H-2 complex, between the H-2K and 
H-2D loci. The Ir genes map in what is now 
designated as the I region of the H-2 system, and as 
the diagram indicates, there are several subregions 
of the I region. In addition to genes determining 
specific immune responses to a wide variety of 
synthetic polypeptide, protein, and isoantigens, 
this region also determines the structure of a series 
of cell surface glycoproteins of 28,000-32,000 MW, 
the I region associated or Ia antigens, which are 
found predominantly on lymphocytes, macro-
phages, sperm, and epidermal cells, and which 
appear to be the antigens responsible for eliciting 
the mixed lymphocyte culture (MLC) reaction in 
man. The S region of the H-2 complex is of 
immunologic interest also, because it has recently 
been shown (D. C. Shreffler, personal communica-
tion) that the serum {3 globulin whose structure is 
determined by this region appears to be part of the 
fourth component of complement. Genes deter-
mining the structure or levels of several compo-
nents of complement are also linked to either the 
H-2 or HLA complex (for references see [2,3]). 
In man, the HLA complex contains a region 
which is apparently analogous to the I region in the 
mouse, in that it determines the structure of the 
antigens eliciting the strongest mixed lymphocyte 
culture reaction between unrelated individuals or 
HLA nonidentical siblings. Crossover studies in a 
number of families have established that the MLC 
locus in man lies outside of the region encompassed 
by the HLA-A and HLA-B loci, and this region has 
currently been given the designation of HLA -D [1]. 
Definitive evidence for localization of specific 
immune response (lr) genes in man has not yet 
been achieved. However, based on evidence 
obtained in the rhesus monkey [4], Ir genes in 
primates appear to map along with the antigens 
eliciting the mixed lymphocyte culture reaction 
and outside the two loci coding for the major, 
serologically detected, ubiquitous major transplan-
tation antigens. Thus, the major difference 
between the HLA complex and the H-2 complex 
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FIG. 1. Schematic diagram of the genetic structure of 
the chromosomal region. 
lies in the fact that the genes determining the MLC 
antigens and the postulated primate immune re-
sponse genes are in a slightly different position 
from the analogous genes in the H-2 complex. 
Recent studies [5] give indications that cell surface 
antigens analogous to the Ia antigens of the mouse 
also exist in man. For a comprehensive review of 
the genetic structure of the HLA complex see [6] or 
the review bibliography in [2]. 
Immune response genes are detected as a pheno-
typic trait by immunization with specific antigens 
and correlation of the immune response with 
particular transplantation types in either mouse or 
man. The serologically detected, ubiquitous trans-
plantation antigens (H-2K and H-2D in the mouse, 
and HLA-A, B, C in man) are detected by isoanti-
sera plus complement in a standard cytotoxic 
assay. In the mouse, the Ia antigens which elicit 
the MLC reaction can be typed for either by a 4- to 
5-day in vitro MLC reaction measuring the pro-
liferative response between allogeneic lymphocytes 
when they are mixed together in vitro, or by spe-
cific isoantisera raised in strains which differ only 
at the I region of the H-2 complex. As noted, these 
antisera detect antigens found primarily on lym-
phocytes, some macrophages, sperm, and epi-
dermal cells. At the present time, MLC eliciting 
antigens in man can be detected primarily 
through the use of MLC typing cells. These 
typing cells are identified by finding individuals 
who are HLA-A and B homozygous, and testing 
them for lack of reactivity in the MLC test with 
their parents, siblings, or children. Failure to 
stimulate first-degree relatives who share one 
HLA haplotype establishes MLC homozygos-
ity. These cells can then be irradiated (to block 
their own proliferation) and used as stimula-
tor cells with the lymphocytes of other indi-
viduals in a "one-way" MLC reaction to deter-
mine whether the lymphocytes of the other indi-
vidual to be tested share the same MLC antigens. 
It is likely that within a very short time, techniques 
will be available for serologically detecting the 
antigens eliciting the MLC reaction, using a 
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fluorescent binding assay. However, at the present 
time typing these antigens requires a rather labori-
ous, 4- to 5-day in vitro MLC system. The typing 
techniques are of importance because: (1) based on 
the analogies of the mouse and the rhesus monkey, 
typing for the MLC antigens appears to be the 
most reliable way of typing for closely linked, 
postulated, specific immune response genes; (2) as 
will be seen below, many associations between the 
HLA system and disease are primarily associations 
with the MLC antigens, and not with the serologi-
cally detected HLA antigens. 
GENETIC CONTROL OF THE IGE ANTIBODY RESPONSE 
The specific IgE antibody response is clearly 
responsible for many of the manifestations of 
allergic or extrinsic hay fever and asthma, and may 
be involved in the pathogenesis of atopic dermati-
tis. At the present time, there is considerable 
evidence to indicate that specific IgE antibody 
responses are under the control of at least two 
autosomal genes. As will be shown below, one of 
these genes appears to be closely associated with 
the HLA system and to determine specific anti-
body responses, and appears to be analogous to a 
specific immune response, or Ir gene, in the mouse. 
The second gene does not control specific IgE 
responses, but rather determines the total level of 
IgE in a particular individual. The interactions of 
these two genetic controls determines the amount 
and specificity of the IgE antibody response, and 
thus determines susceptibility to disease resulting 
from this type of antibody response. 
Evidence for HLA-linked genetic control of spe-
cific IgE antibody responses came first from the 
studies of Levine, Stember, and Fotino [7], who 
analyzed the association of HLA chromosomal 
types (haplotypes) with IgE antibody response to 
ragweed allergen E, and with clinical symptoms of 
ragweed hay fever and asthma. This study was 
carried out in seven families in which a proband 
was initially identified with classical ragweed aller-
gen E hay fever and/or asthma, and with a strong 
family history of ragweed allergy. HLA typing, skin 
testing for reaginic sensitivity to ragweed allergen 
E, and examination for a history of symptoms of 
ragweed hay fever were then carried out on all the 
available family members. A correlation was 
sought between the presence in family members of 
a reaginic antibody response to ragweed allergen E 
and the presence of symptoms of ragweed hay 
fever, and the presence of one of the two HLA 
chromosomal types (haplotypes) of the proband. A 
very strong correlation within each family was 
obtained between the presence of one of the HLA 
chromosomes of the proband and symptoms of 
ragweed hay fever and a positive skin test to 
ragweed allergen E. Although there was a slightly 
increased incidence of one HLA-B antigen 
(HLA-B7) in the individuals with ragweed h~y 
fever, it is important to note that while in each of 
the families one particular HLA chromosome was 
associated with reaginic antibody to ragweed aller-
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gen E, the same HLA-B antigen was not found 
associated with these findings in all seven families. 
In this study of a total of 46 family members, 20 
of 26 possessing the "hay fever haplotype" of the 
propositus had ragweed hay fever and a positive 
skin test. Of those lacking the hay fever haplotype 
none had either ragweed hay fever or a positive 
skin test, while 3 had a weakly positive or equivo-
cal skin test. In the same study, it was shown that 
the IgG response to ragweed allergen E also cor-
related with the same HLA chromosomal type, but 
that this chromosome was not correlated with 
sensitivity to another unrelated grass allergen. 
This study indicates that a specific IgG and IgE 
response to ragweed allergen in these families 
appears to be under the control of a gene which is 
linked to the HLA complex, but is not identical 
with antigens at the HLA-A or HLA-B locus, since 
no association was found at the population level in 
these seven families , between ragweed allergen E 
response and possession of a particular HLA-A or 
HLA-B antigen. 
This study is of particular importance for two 
reasons: First, it demonstrates a correlation 
(within families , although not at the population 
level) between HLA type, specific antibody re-
sponse to ragweed allergen E, and symptoms of 
ragweed hay fever. Such a three-way correlation is 
the minimum requirement for establishing that a 
histocompatibility-linked specific immune re-
sponse may be etiologic in resistance or suscepti-
bility to a particular disease. This study thus 
constitutes the first evidence for histocompatibili-
ty-linked specific immune response genes in man , 
as well as the first evidence that these genes can 
cause a specific disease. The second point is that 
the specific ragweed allergen E response correlated 
with a particular HLA chromosome within fami-
lies, but that no definite correlation was found in 
population studies between any particular HLA 
antigen and the ragweed allergen E response. This 
finding indicates that the genetic control is due to 
a gene on the HLA chromosome, other than the 
two genes tested for (the HLA-A and HLA-B loci). 
This is of particular import for studies designed to 
detect an association between HLA and a number 
of diseases where the specific inciting agent may 
not be as readily identifiable. Because of the close 
association in the mouse, and quite probably in 
man, between specific Ir genes and genes deter-
mining the structure of the antigens eliciting the 
MLC reaction, it is apparent that studies of this 
sort should utilize MLC typing techniques as well 
as HLA typing. Several examples now exist of 
diseases which show little or no association with 
HLA, but a very definite association with specific 
MLC types, and these will be referred to briefly 
below. 
As noted above, specific immune response genes 
determining the IgG and IgE antibody response to 
a particular antigen are not the only genetic 
control of the IgE antibody response. Hamburger 
and his associates [8] have shown that total serum 
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IgE levels, independent of any specific response, 
are under the control of an autosomal gene which is 
not linked to the HLA system. This gene appears 
to control total IgE levels. Marsh [9] has shown a 
definite interaction between total serum IgE level 
and HLA type in determining allergy to rye grass 
allergen and ragweed allergen . There is also a 
weak, but definite, association at the population 
level between HLA-B7 and the specific immune 
response to a highly purified antigen extracted 
from ragweed, the Ra5 antigen. Marsh [9] carried 
out a population study analyzing the association 
between HLA type and rye grass allergy and 
ragweed allergy, and then plotted the results as a 
function of total serum IgE levels in individual 
patients. These results are shown in Figure 2 which 
shows the frequency of one HLA type at the B 
locus, HLA-B8, as a function of the total serum IgE 
level in individual patients. As can be seen, in 
those with very low serum IgE levels (in the first 
quartile) , the incidence of HLA-8 was markedly in-
creased in those patients allergic to rye group I 
allergens, and markedly decreased in those allergic 
to ragweed allergen E only. In those patients with 
higher levels of total serum IgE, the correlation 
with HLA type decreased rapidly, and was not 
significantly different from the general population 
frequency. These results suggest that a gene prefer-
entially associated with HLA-B8 determines the 
immune response to rye group I allergens, while a 
gene preferentially associated with HLA-B7 deter-
mines the immune response to ragweed allergen E. 
These HLA-linked genes, presumably specific 
immune response genes , have an effect on suscepti-
bility to allergic disease primarily in those individ-
uals who have a low total serum IgE level, and have 
much less of an effect in those individuals who 
have inherited a high serum IgE level, determined 
by genes on a different chromosome. The two genes 
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FIG. 2. Distribution of HLA-B8. (Reproduced with 
permission from Marsh [9]) 
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interact to determine susceptibility to specific 
allergic diseases. 
Multigenic inheritance of susceptibility or resist-
ance to diseases is a general theme that recurs 
frequently in analysis of the association of the HLA 
system with susceptibility to a wide variety of 
diseases. All of these associations will not be 
reviewed here (see [10, 11]). With respect to atopic 
dermatitis, the lessons are clear. Studies designed 
to probe the genetic determination of predisposi-
tion to atopic dermatitis should focus on determin-
ing the role of genetic control of total serum IgE 
levels, as well as attempting to demonstrate associ-
ation of atopic dermatitis with particular HLA 
chromosomal types within families showing a high 
incidence of atopic dermatitis. If these studies are 
negative, both family and population surveys at-
tempting to demonstrate a correlation between 
particular MLC types and this disease should be 
done. 
There are now several examples of diseases 
which show weak or no correlation with the HLA 
antigens, but a very strong association with the 
antigens eliciting the MLC reaction. Perhaps the 
best documented example of this is multiple scle-
rosis [12]. Population studies of the association of 
HLA with multiple sclerosis have shown a very 
weak association with an increased incidence of 
HLA-7 in the patient population. Thus, HLA-7 
occurs in 25 % of the normal population and in 36 % 
of patients with multiple sclerosis. However, when 
MLC typing is carried out using MLC homozygous 
typing cells, the MLC type originally designated as 
7a, which is found in 15% of the normal population, 
is found in 70% of patients with multiple sclerosis, 
particularly those with severe, unremitting dis-
ease. This has led to the postulate that many 
associations between HLA and specific diseases in 
fact reflect stronger underlying associations 
between a particular MLC type and that disease, 
and the association with the HLA antigen is 
detected because of a preferential association of 
that MLC type with one particular HLA type. This 
phenomenon of preferential association between 
one particular MLC type and a particular HLA 
antigen, or between two particular HLA antigens, 
is known as linkage disequilibrium, and is frequent 
in the HLA system. For a discussion of this 
phenomenon see [10]. These points are particularly 
pertinent because studies to date have shown no 
association between HLA antigens and atopic 
dermatitis [13]. 
As has been emphasized above, most of the 
diseases in which there is an association between 
the HLA complex and a specific disease entity 
are ones in which multiple genes determine inheri-
tance of resistance or susceptibility. The same is 
likely to be true for atopic dermatitis, and other 
types of genetic polymorphism of possible rele-
vance should certainly be sought. For example, it 
has been demonstrated that there is a marked 
individual variation in the amount of mediators 
released from basophils after passive sensitization 
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with a standard amount of reaginic antibody to a 
known allergen. Genetic variations in the amount 
of mediator release after a standard challenge, as 
well as variations in response to pharmacologic 
agents, should certainly be sought in atopic derma-
titis and related conditions. 
ASSOCIATION OF THE HLA COMPLEX WITH OTHER 
DERMATOLOGIC CONDITIONS 
At the present time, associations between anti-
gens of the HLA system and a wide variety of 
diseases have been well documented in reports 
from a number of laboratories [10, 11]. These 
include rheumatic, neurologic, endocrinologic, gas-
trointestinal, neoplastic, and "autoimmune" dis-
eases. Before describing the associations with spe-
cific dermatologic conditions, a few general points 
should be made. The first is that there are a 
number of theoretical reasons for an association 
between HLA and disease. Many of these were 
originally put forth by Snell [14]. The Table gives a 
list of some of these theoretical possibilities. While 
all of these mechanisms are theoretically possible, 
experimental evidence in animal models so far 
indicates that definite examples exist for reasons 3, 
4, and 5. Since for most of the associations between 
HLA and disease, with the probable exception of 
ragweed hay fever and asthma, the action of a 
specific immune response gene has not been defi-
nitely established, alternate possibilities must be 
kept in mind. However, it should also be noted that 
almost all of the HLA and disease associations 
described to date are with the second, or HLA-B, 
locus. Since this is the HLA locus which maps 
closest to the genes determining the structure of 
the MLC (la) antigens, the region where Ir genes 
also presumably map in man, it seems unlikely 
that these associations are due to the HLA anti-
gens themselves, and more likely that the associa-
tions are with MLC antigens or with specific 
immune response genes. Supporting evidence for 
this hypothesis comes from the findings of Terasa-
ki and Mickey [15] who have obtained evidence 
that the association of a particular HLA-B antigen 
with a disease involves a selective association with 
one particular chromosomal combination of that 
antigen. For example, HLA-A2, B27 is found much 
more frequently as a percentage of all the chromo-
somes bearing B27 in the ankylosing spondylitis 
population than in the normal control population. 
TABLE. Theoretical reasons for HLA and disease 
associations 
1. HLA antigen functions as a-viral or toxin receptor 
2. HLA antigen has antigenic similarity to a viral or 
bacterial antigen 
3. HLA antigen is incorporated into the virus protein 
coat 
4. HLA antigen and viral antigen associate together on 
the cell surface to forma "new" antigenic determi-
nant 
5. Effect of a linked immune response gene 
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This preferential association of the disease with a 
particular combination of antigens at the HLA-A 
and B loci suggests that neither antigen is the 
genetic factor predisposing to the disease, but 
rather that another gene on the chromosome , 
showing a preferential association with the com-
bination HLA-A2, B27 is the genetic factor which 
predisposes to ankylosing spondylitis. Similar evi-
dence is present for a number of other associations 
between HLA and specific diseases . 
In addition to the fact that very few definite 
associations have been established between the 
action of a specific immune response gene and 
susceptibility to a specific disease, the mechanism 
of action of specific immune response genes is still 
a matter of current investigation. (For reviews see 
[2, 3,10, 16]). The available evidence indicates that 
the histocompatibility-linked specific immune re-
sponse genes determine recognition of antigenic 
foreignness by a mechanism other than specific 
antibody itself. This conclusion is based on a 
variety of experiments which indicate that these 
genes control T-cell recognition of carrier determi-
nants on antigen, cell-mediated immunity, the 
abilities of T -cells to "help " B-cells to produce 
antibody to a specific antigenic determinant, and 
the fact that genes in the major histocompatibility 
complex show no association or linkage with the 
genes determining the structure of the known 
classes of immunoglobulins. While there is still 
controversy over whether this genetic control of the 
recognition of antigenic foreignness is expressed 
exclusively in T -cells, or in T -cells and B-cells, it 
seems clear that the Ir genes constitute a second, 
nonimmunoglobulin, specific antigen recognition 
system which is required for the development of 
the complete array of immune responses to a given 
antigen. 
The two dermatologic conditions which have 
shown the strongest association between the HLA 
system and specific diseases are psoriasis and 
dermatitis herpetiformis [17-26] . Psoriasis vulgaris 
is associated with two antigens at the HLA-B 
locus-HLA-B13 and HLA-B17. HLA-B13 has an 
incidence in the general population of 3 to 4% and 
is found in some 15 to 20 % of patients with 
psoriasis vulgaris. HLA-B17 has an incidence in 
the general population of 8% and is found in 25 to 
35 % of patients with psoriasis vulgaris. The com-
bined incidence of these two antigens in the 
general population is 10 to 12 %, and in various 
series the combined incidence of these two antigens 
in the psoriatic population varies from 50 to 60 %. 
Family studies have shown that HLA-B13 in some 
families, and HLA-B17 in other families , clearly 
segregate with psoriasis; and in most of the kin-
dreds in which one or the other of these antigens is 
segregating, most of the individuals with the dis-
ease carry the HLA antigen segregating in that 
family. However, it is equally clear in the same 
kindreds there are frequent findings of individuals 
with psoriasis who lack either the HLA-B13 or the 
HLA-B17 antigen. This indicates that these anti-
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gens are genetic factors which increase the genetic 
predisposition to psoriasis, but can only be one of 
several genetic factors determining susceptibility. 
Several other descriptive phenomena deserve 
comment. First, while psoriasis vulgaris shows the 
above-described association with HLA-B13 and 
HLA-B17, pustular psoriasis does not [25]. Analy-
sis of the psoriasis vulgaris age population shows 
that those patients lacking HLA-B13 and B17 have 
a bimodal distribution of age of onset with peaks at 
15 and approximately 50 years of age, while those 
patients carrying either HLA-B13 or HLA-B17 
have a unimodal distribution of age of onset with a 
peak at age 15 and a very low incidence of onset 
beyond the age of 45 . Because of the well-known 
observation that streptococcal infections may trig-
ger psoriasis, there has been some speculation [25] 
that some HLA antigens may cross-react with 
streptococcal antigens. So far no evidence has been 
obtained for this hypothesis [25], but further 
studies are clearly indicated. While some minor 
immunologic abnormalities have been described in 
psoriasis [21], no direct evidence implicating an 
immunologic abnormality or the action of an 
immune response gene has yet been forthcoming. 
In patients with psoriatic arthritis, HLA-B13 is 
slightly increased in incidence, HLA-B17 is found 
in almost the same incidence as in psoriatic 
patients without arthritis , and HLA-B27 is found 
in an increased incidence in patients with psoriasis 
vulgaris with arthritis , as well as in patients with 
pustular psoriasis and arthritis. Since HLA-B27 is 
found in extremely high incidence in ankylosing 
spondylitis and Reiter 's disease, this finding sug-
gests a relationship between the arthritis of psoria-
sis and that in ankylosing spondylitis and Reiter's 
disease [26]. 
The other skin disease which shows a prominent 
association with the HLA system is dermatitis 
herpetiformis. HLA-B8 is found in some 24 % of the 
normal population and between 58 to 60% of 
patients with dermatitis herpetiformis [27-32]. 
This finding has several interesting ramifications . 
First, there is a definite relationship between 
dermatitis herpetiform is and celiac disease , or 
gluten-sensitive enteropathy. Approximately 60% 
of patients with dermatitis herpetiformis have 
been found to show the small intestinal epithelial 
changes characteristic of celiac disease. This rela-
tionship is of interest because of the fact that celiac 
disease shows an extremely high incidence of 
HLA-B8. The HLA-B8 antigen is present in 80 to 
90% of patients with adult onset, gluten-sensitive 
enteropathy. There is some controversy in the 
literature as to whether HLA-B8 is found in a 
higher incidence in those patients with dermatitis 
herpetiformis who have abnormal jejunal biopsies 
[27] or whether the incidence of HLA-B8 is the 
same in dermatitis herpetiform is patients with and 
without abpormal jejunal biopsies [28]. As with 
other diseases showing an association with the 
HLA system, differences in incidence of a particu-
lar HLA antigen in that disease may reflect hetero-
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geneity in the disease; the polygenic nature of 
inheritance of many of these diseases; and differ-
ences in classification and diagnosis of disease 
entities among different investigators. While there 
is abundant evidence of immunologic aberration 
in dermatitis herpetiformis and celiac disease 
[31-33] and while there has been considerable 
speculation that both celiac disease and dermatitis 
herpetiform is may represent an abnormal immune 
response to gluten and/or the gliadin component of 
gluten, definite evidence that would establish such 
a phenomenon as an underlying cause of the 
intestinal abnormalities seen in celiac disease and 
the skin lesions seen in dermatitis herpetiformis 
has not yet been found. Some studies [34] have 
shown that the association between HLA-B8 and 
celiac disease is specifically for HLA-B8 and not 
for an associated MLC type, but further evidence 
is required before it can be concluded that this is 
an example of a disease association due to the HLA 
antigen itself, rather than to a linked gene. The 
prominent role of HLA-B8 or a linked gene in 
predisposition to celiac disease and to dermatitis 
herpetiformis is clear. As with many other HLA 
and disease associations, the mechanism remains 
to be worked out. Indeed, perhaps the major 
significance of all of these associations is that they 
offer new avenues for epidemiologic, diagnostic, 
nosologic, and pathogenetic studies. 
While a number of reports have appeared show-
ing very weak associations between HLA and a 
particular dermatologic condition, many of these 
await confirmation, and will therefore not be 
mentioned here. It should be noted that there have 
been reports [35] of an association between 
HLA-B5 and Behvet's disease. While this is a rare 
disease, the association of this disease with anti-
gens of the HLA system again raises interesting 
problems concerning the possible etiology of this 
disease. 
CONCLUSIONS 
During the past several years, the role of the 
major histocompatibility system in regulating the 
immune response has become apparent [2]. Direct 
evidence is now available that genes in the major 
histocompatibility complex interact with other 
genes to determine the level of specific IgE anti-
body responses, and thereby to predispose to 
reaginic hay fever and asthma. It is equally clear 
that genes in the major histocompatibility system 
have strong influence on predisposition to a wide 
variety of diseases [10, 11], among them at least 
two dermatologic conditions-psoriasis vulgaris, 
and dermatitis herpetiformis. As with most HLA 
and disease associations, the mechanism of this 
association is not yet known, and it remains to be 
seen whether genes regulating the immune re-
sponse are responsible for this relationship. Fur-
ther epidemiologic, analytic, and pathogenetic 
studies should permit us to understand the nature 
of these associations, and perhaps to understand 
the etiology of these diseases more clearly. 
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DISCUSSION 
Austen: Please clarify your histocompatibility ter-
minology by repetition. 
McDevitt: In tbe initial terminology, the genes for the 
two serologically detectable HLA antigens found on all 
cells were called the LA and FOUR loci. They were then 
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called SD-l and SD-2 (for serologically detectable.) 
These loci are now designated the HLA-A and HLA-B 
loci. A third serologically detectable locus, the AJ locus, 
is now called the HLA-C locus . The mixed lymphocyte 
culture, or MLC, antigens were originally detected by 
lymphocyte culture methods and were thus called the 
lymphocyte determined or LD antigens, coded for by the 
MLC or LD loci. The genes for these antigens have now 
been designated as the IlLA-D locus. 
Katz: Strober et al [Ann Intern Med 83:242, 1975] re-
cently reviewed the strong association between gluten-
sensitive enteropathy (GSE) and HLA-B8. Since a large 
percentage of patients with dermatitis herpetiformis 
(DH) have the gut morphologic changes of GSE and the 
gut becomes normal with gluten-free diet, we studied the 
association between HLA types and DH. In our original 
study [Katz et al: J Clin Invest 51:2977, 1972] we found 
that 58% of patients with DH have HLA-B8. These pa-
tients have been diagnosed clinically, histologically, and 
by a good response to sulfones or sulfapyridine. We have 
since determined the relative frequency of gut abnormal-
ity in patients with HLA-B8 and in those without HLA-B8 
and found an even stronger (> 80%) association between 
DH, gut abnormalities, and HLA-B8 [Gebhard et al: 
Lancet 2:760, 1973, and J Clin Invest 54:98, 1974]. In the 
past year we have studied a new group of DH patients and 
as an additional diagnost ic criterion, have included for 
study only those patients with IgA deposits in the dermal 
papillae or linearly at the basement membrane zone. We 
have found that these patients have an incidence of 85% 
(28/33 patients) of HLA-B8. This agrees with the find-
ing of Janet Marks ' group in Newcastle Upon Tyne that 
35 to 39 (89%) DH patients with IgA skin deposits have 
HLA-B8. The probable importance of these findings may 
be the association of a gene responsible for the immune re-
sponse in DH being closely linked to HLA-B8 in these pa-
tients. 
McDevitt: The conflict over the incidence of gut 
abnormalities and HLA-B8 in DH is confusing. It raises 
the question of whether there is a problem in diagnostic 
classification of these patients which might explain the 
discrepancies. 
Soter: In considering the relation between psoriasis 
and HLA antigens, would you comment on the types of 
arthritis in these patients? 
McDevitt: In patients with psoriasis and arthritis, 
there is an increased incidence of HLA-13 and HLA-17. 
In addition, among psoriatic arthritics, those with sac-
roiliitis have a 35% incidence of HLA-27; while those 
without sacroiliitis have an 18 % incidence of HLA-27. 
More detailed subgrouping needs to be done , preferably 
with family studies. 
Austen: Why do the pustular and vulgaris forms of 
psoriasis differ in histocompatibility linkage? 
McDevitt: Psoriasis vulgaris is associated with 
HLA-13 and HLA-17 . Pustular psoriasis shows no HLA 
association. MLC typing in these diseases has not yet 
been reported. 
Provost: Dr. Katz, would you consider a diagnosis of 
dermatitis herpetiform is in the absence of IgA skin 
deposition? Have you repeated your gut stu'dies in those 
dermatitis herpetiform is patients who have IgA skin 
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deposition? 
Katz: I think from Fry's studies and our own, one is 
hard pressed to make a diagnosis of DH when there are no 
IgA deposits. In answer to your second question, 12 of 15 
DH patients studied with IgA deposits had gut abnormal-
ities as defined by morphologic criteria and alkaline 
phosphatase activity of gut epithelial cells. 
Gigli: How is it possible that the Ss protein in mouse is 
identical to C4 when the structure of the two proteins as 
assessed by disc-gel electrophoresis is totally different? 
McDevitt: The evidence I cite is from Shreffler's 
laboratory. Rabbit antimouse Ss protein reacts with 
human C4, and antihuman C4 reacts with the murine Ss 
protein . This does not mean that the Ss locus is the entire 
structural gene for C4. C4 has three polypeptide chains 
-al pha, beta, and gamma. The gamma chain has a MW 
of 33 ,000-similar to the Ia antigens-and may have 
arisen by a series of tandem duplications from a common 
ancestral gene which gave rise to both the Ia and C4 
garllma chain gene. 
Epstein: Terasaki has mentioned that in Jews with 
psoriasis there may be an association with HLA-16 rather 
than HLA-17. Has this finding held up? 
McDevitt: Several studies have shown a slight to 
definite increase of HLA-16 in psoriasis. Most of them do 
not give an ethnic breakdown of the patient population so 
that a definite answer to your question cannot be given, 
but is probably available in the already collected patient 
data. 
Kantor: I would like to call attention to the recent 
findings of Zinkernogel and Doherty who investigated 
lymphocyte-mediated cytotoxicity directed towards tar-
get cells infected with either ectromelia, Sendai, or 
lymphocytic choriomeningitis viruses. They found that 
the killer cells not only had to be specifically sensitive to 
viral antigens but they had to share H-2 specificity as well. 
Shearer has described a similar situation in non viral 
systems where target cells were derivatized with haptenic 
groups. The importance of these findings is the realiza-
tion that the etiology of several if not most diseases 
depends upon the host response, genetically controlled to 
the disease agent. 
Windhorst: Could you comment on the mechanisms 
whereby genetically controlled factors might be responsi-
ble for disease? It seems to me you have alluded to at 
least two; one in which there is a genetically controlled 
specific immune response for , say, an infectious agent, 
and a second whereby a genetically controlled substance , 
such as an HLA antigen, might be the target for an 
otherwise "ordinary" or " normal" immune response. 
McDevitt: The evidence from several laboratories 
shows that cytotoxic T -cells appear to recognize not just a 
foreign antigen on the cell surface, such as TNP or the 
ectromelia virus, but a combination of the foreign antigen 
with either the K- or D-cell surface antigens coded by the 
H-2 complex. The ability to generate these cytotoxic 
T -cells appears to be under I region control by an 
unknown mechanism, perhaps an Ir gene. Thus, this 
mechanism of HLA and disease association may operate 
via an Ir gene also. The fact that almost all HLA and I 
disease associations are with the second or B locus, or the 
D locus, supports this idea. 
